Stomach cancer CT: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{CMG}}{{AE}}{{PSD}}
{{CMG}}{{AE}}{{PSD}}


Line 8: Line 9:


==CT==
==CT==
 
* CT is currently the staging modality of choice because it can help identify the primary tumor.
CT is currently the staging modality of choice because it can help identify the primary tumor, assess for local spread, and detect nodal involvement and distant metastases
* It is best suited to evaluating widely metastatic disease, especially hepatic or adnexal metastases, ascites, or distant nodal spread, although biopsy confirmation is recommended because of the risk of false-positive findings.
 
* Peritoneal metastases and hematogenous metastases smaller than 5 mm are frequently missed by CT in 20 percent of patients [25].
Demonstration of lesions facilitated by negative contrast agents (water or gas):
* CT accurately assesses the T stage of the primary tumor in 50 to 70 percent of cases [29-35].
* Sensitivity and specificity rates for regional nodal metastases range from 65 to 97, and 49 to 90 percent, respectively [36-40].
Demonstration of lesions facilitated by negative contrast agents:<ref>http://radiopaedia.org/articles/gastric-carcinoma</ref>


*A polypoid mass with or without ulceration
*A polypoid mass with or without ulceration
Line 17: Line 20:
*Ulceration: gas-filled ulcer crater within mass
*Ulceration: gas-filled ulcer crater within mass
*Infiltrating carcinoma: wall thickening and loss of normal rugal fold pattern  
*Infiltrating carcinoma: wall thickening and loss of normal rugal fold pattern  
Calcifications are rare but when present, they are usually mucinous adenocarcinoma.<ref>http://radiopaedia.org/articles/gastric-carcinoma</ref>


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Disease]]
[[Category:Disease]]

Revision as of 22:19, 14 November 2017


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Stomach cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Stomach Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Endoscopy and Biopsy

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Stomach cancer CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Stomach cancer CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Stomach cancer CT

CDC on Stomach cancer CT

Stomach cancer CT in the news

Blogs on Stomach cancer CT

Directions to Hospitals Treating Stomach cancer

Risk calculators and risk factors for Stomach cancer CT

Overview

Abdominal CT scan may be helpful in the diagnosis of stomach cancer.

CT

  • CT is currently the staging modality of choice because it can help identify the primary tumor.
  • It is best suited to evaluating widely metastatic disease, especially hepatic or adnexal metastases, ascites, or distant nodal spread, although biopsy confirmation is recommended because of the risk of false-positive findings.
  • Peritoneal metastases and hematogenous metastases smaller than 5 mm are frequently missed by CT in 20 percent of patients [25].
  • CT accurately assesses the T stage of the primary tumor in 50 to 70 percent of cases [29-35].
  • Sensitivity and specificity rates for regional nodal metastases range from 65 to 97, and 49 to 90 percent, respectively [36-40].

Demonstration of lesions facilitated by negative contrast agents:[1]

  • A polypoid mass with or without ulceration
  • Focal wall thickening with mucosal irregularity or focal infiltration of wall
  • Ulceration: gas-filled ulcer crater within mass
  • Infiltrating carcinoma: wall thickening and loss of normal rugal fold pattern

References

Template:WH Template:WS